-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Black Diamond Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2018 to Q1 2025.
- Black Diamond Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was $53.4M.
- Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$62.3M, a 6.62% increase from 2023.
- Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$66.7M, a 21.6% increase from 2022.
- Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$85.1M, a 15% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)